Certificate in Lifestyle Medicine

---

LIVEFACE-TO-FACEDHPAMANPA

Friday, October 17, 2025, 1:00 PM - Tuesday, October 21, 2025, 2:45 PM, Hilton Doha Hotel, Doha, Qatar

The Certificate in Lifestyle Medicine course is a 5-day certificate program, administered by the Institute for Population Health at Weill Cornell Medicine-Qatar, which will provide healthcare practitioners with lifestyle medicine education and competencies to aid in the evaluation, prevention and management of lifestyle-related chronic health conditions to reduce chronic disease morbidity and the suffering associated with it. Additionally, the course will enable healthcare practitioners to engage in dialogue and meaningful discussions with their patients about the potential for lifestyle medicine ultimately leading to improved overall quality of life and patient outcomes. The course will be delivered by means of didactic lectures, small group interactive discussions, review of clinical cases, and distance online learning. There are two components to the course, which must be successfully completed to meet the course requirements in order to receive the Certificate in Lifestyle Medicine. The two components are a) attendance and participation in the onsite/in-person 30-hour unit comprising lectures and interactive discussions, b) self-study/online 30-hour unit, which requires completing the Foundations of Lifestyle Medicine Board Review Course, an evidence-based course designed to provide an overview of essential elements of lifestyle medicine.

1. Discuss lifestyle medicine and its competencies.
2. Examine the evidence of lifestyle medicine interventions in the prevention and management of chronic disease.
3. Review emerging lifestyle medicine specific topics such as clinical processes, positive psychology, social connectedness, therapeutic alliances with patients, and environmental health.
4. Summarize lifestyle measures for chronic diseases

ACCME Accreditation Statement  The Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians ACCME Credit Designation Statement The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. DHP Accreditation Statement Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Department of Healthcare Professions - Accreditation Section (DHP-AS). DHP Credit Designation Statement This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 30 hours.

Disclosure of Relationships/Content Validity 

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health’s Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias.

Scientific Planning Committee

Joel Anison, Mark Dimon Santos, Nour Makkia, Raji Anand, Ravinder Mamtani, Rejeena Adayakandi, Samaah Shams Chalil, Sandhya Vijayakumar, Sohaila Cheema:

• Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.  
• Will not be discussing unlabeled/unapproved use of drugs or products.

Course Directors

Ravinder Mamtani, Sohaila Cheema:

• Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.  
• Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty

Ahmad Almulla, Benjamin Kligler, Javaid Sheikh, Ravinder Mamtani, Sarah Burshan, Shahrad Taheri, Simon Matthews, Sohaila Cheema, Stephan Herzog, Wayne Dysinger:

• Have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose.  
• Will not be discussing unlabeled/unapproved use of drugs or products.  

Course Administrator

Samaah Shams Chalil:

• Has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose. 
• Will not be discussing unlabeled/unapproved use of drugs or products. 

---

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

---

Evaluation

An evaluation will be conducted online post activity. All participants are required to complete the evaluation to receive a certificate. The evaluation allows us to assess the degree to which the activity met its objectives. It will also guide the planning of future activities and inform decisions about improving the educational program.

Certificate in Lifestyle Medicine

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.